Charles River Laboratories (CRL) Tops Q2 EPS by 28c; Offers Guidance
Tweet
Share
E-mail
Get Alerts CRL Hot Sheet
Price: $278.06 -1.28%
Revenue Growth %: -4.3%
Financial Fact:
Provision (benefit) for income taxes: 15.57M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: -4.3%
Financial Fact:
Provision (benefit) for income taxes: 15.57M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q2 EPS of $3.02, $0.28 better than the analyst estimate of $2.74. Revenue for the quarter came in at $1 billion versus the consensus estimate of $976.13 million.
FY2026 Outlook-
EPS between $11.15 to $11.45 versus consensus $11.09.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Leidos wins $85m Air Force contract for aerospace design
- Trump announces security deal with Denmark on Greenland
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
